Joachim Vandepitte, Mieke Roelants, Ben Van Cleynenbreugel, Klaudia Hettinger, Evelyne Lerut, Hendrik Van Poppel, Peter de Witte
Journal of Biomedical Optics, Vol. 16, Issue 1, 018001, (January 2011) https://doi.org/10.1117/1.3533316
TOPICS: Luminescence, Photodynamic therapy, Tumors, Bladder, Bladder cancer, Oxygen, Tissues, In vitro testing, Microelectromechanical systems, Fluorescence correlation spectroscopy
Polyvinylpyrrolidone (PVP)-hypericin is a potent photosensitizer that is used in the urological clinic to photodiagnose with high-sensitivity nonmuscle invasive bladder cancer (NMIBC). We examined the differential accumulation and therapeutic effects of PVP-hypericin using spheroids composed of a human urothelial cell carcinoma cell line (T24) and normal human urothelial (NHU) cells. The in vitro biodistribution was assessed using fluorescence image analysis of 5-μm cryostat sections of spheroids that were incubated with PVP-hypericin. The results show that PVP-hypericin accumulated to a much higher extent in T24 spheroids as compared to NHU spheroids, thereby reproducing the clinical situation. Subsequently, spheroids were exposed to different PDT regimes with a light dose ranging from 0.3 to 18J/cm2. When using low fluence rates, only minor differences in cell survival were seen between normal and malignant spheroids. High light fluence rates induced a substantial difference in cell survival between the two spheroid types, killing ∼80% of the cells present in the T24 spheroids. It was concluded that further in vivo experiments are required to fully evaluate the potential of PVP-hypericin as a phototherapeutic for NMIBC, focusing on the combination of the compound with methods that enhance the oxygenation of the urothelium.